SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-124922
Filing Date
2018-04-20
Accepted
2018-04-20 16:19:55
Documents
2
Period of Report
2018-06-05
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d541967ddef14a.htm DEF 14A 529541
2 GRAPHIC g541967s1.jpg GRAPHIC 6091
  Complete submission text file 0001193125-18-124922.txt   539202
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 18766922
SIC: 2834 Pharmaceutical Preparations